315 related articles for article (PubMed ID: 30471107)
1. Cancer stem cells as a therapeutic target in bladder cancer.
Aghaalikhani N; Rashtchizadeh N; Shadpour P; Allameh A; Mahmoodi M
J Cell Physiol; 2019 Apr; 234(4):3197-3206. PubMed ID: 30471107
[TBL] [Abstract][Full Text] [Related]
2. Bladder cancer stem cells: biological and therapeutic perspectives.
Goodwin Jinesh G; Willis DL; Kamat AM
Curr Stem Cell Res Ther; 2014 Mar; 9(2):89-101. PubMed ID: 24236543
[TBL] [Abstract][Full Text] [Related]
3. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
[TBL] [Abstract][Full Text] [Related]
4. Determinants of resistance to chemotherapy and ionizing radiation in breast cancer stem cells.
Pavlopoulou A; Oktay Y; Vougas K; Louka M; Vorgias CE; Georgakilas AG
Cancer Lett; 2016 Oct; 380(2):485-493. PubMed ID: 27450721
[TBL] [Abstract][Full Text] [Related]
5. Emerging Roles of Cancer Stem Cells in Bladder Cancer Progression, Tumorigenesis, and Resistance to Chemotherapy: A Potential Therapeutic Target for Bladder Cancer.
Abugomaa A; Elbadawy M; Yamawaki H; Usui T; Sasaki K
Cells; 2020 Jan; 9(1):. PubMed ID: 31963556
[TBL] [Abstract][Full Text] [Related]
6. Subpopulations of stem-like cells in side population cells from the human bladder transitional cell cancer cell line T24.
Ning ZF; Huang YJ; Lin TX; Zhou YX; Jiang C; Xu KW; Huang H; Yin XB; Huang J
J Int Med Res; 2009; 37(3):621-30. PubMed ID: 19589244
[TBL] [Abstract][Full Text] [Related]
7. Bladder cancer stem cells.
Tran MN; Goodwin Jinesh G; McConkey DJ; Kamat AM
Curr Stem Cell Res Ther; 2010 Dec; 5(4):387-95. PubMed ID: 20955163
[TBL] [Abstract][Full Text] [Related]
8. An Oncofetal Glycosaminoglycan Modification Provides Therapeutic Access to Cisplatin-resistant Bladder Cancer.
Seiler R; Oo HZ; Tortora D; Clausen TM; Wang CK; Kumar G; Pereira MA; Ørum-Madsen MS; Agerbæk MØ; Gustavsson T; Nordmaj MA; Rich JR; Lallous N; Fazli L; Lee SS; Douglas J; Todenhöfer T; Esfandnia S; Battsogt D; Babcook JS; Al-Nakouzi N; Crabb SJ; Moskalev I; Kiss B; Davicioni E; Thalmann GN; Rennie PS; Black PC; Salanti A; Daugaard M
Eur Urol; 2017 Jul; 72(1):142-150. PubMed ID: 28408175
[TBL] [Abstract][Full Text] [Related]
9. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
[TBL] [Abstract][Full Text] [Related]
10. Cancer stem cells: an approach to identify newer therapeutic targets.
Srivastava S; Krishna S
J Stem Cells; 2009; 4(2):123-31. PubMed ID: 20232597
[TBL] [Abstract][Full Text] [Related]
11. Curcumin inhibits bladder cancer stem cells by suppressing Sonic Hedgehog pathway.
Wang D; Kong X; Li Y; Qian W; Ma J; Wang D; Yu D; Zhong C
Biochem Biophys Res Commun; 2017 Nov; 493(1):521-527. PubMed ID: 28870814
[TBL] [Abstract][Full Text] [Related]
12. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
[TBL] [Abstract][Full Text] [Related]
13. Side population and cancer stem cells: therapeutic implications.
Moserle L; Ghisi M; Amadori A; Indraccolo S
Cancer Lett; 2010 Feb; 288(1):1-9. PubMed ID: 19523754
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapeutics-induced Oct4 expression contributes to drug resistance and tumor recurrence in bladder cancer.
Lu CS; Shieh GS; Wang CT; Su BH; Su YC; Chen YC; Su WC; Wu P; Yang WH; Shiau AL; Wu CL
Oncotarget; 2017 May; 8(19):30844-30858. PubMed ID: 27244887
[TBL] [Abstract][Full Text] [Related]
15. Targeting breast cancer stem cells.
Liu S; Wicha MS
J Clin Oncol; 2010 Sep; 28(25):4006-12. PubMed ID: 20498387
[TBL] [Abstract][Full Text] [Related]
16. Ovarian cancer stem cell: A potential therapeutic target for overcoming multidrug resistance.
Mihanfar A; Aghazadeh Attari J; Mohebbi I; Majidinia M; Kaviani M; Yousefi M; Yousefi B
J Cell Physiol; 2019 Apr; 234(4):3238-3253. PubMed ID: 30317560
[TBL] [Abstract][Full Text] [Related]
17. Targeted molecular ablation of cancer stem cells for curing gastrointestinal cancers.
Kim YS; Lee HJ; Park JM; Han YM; Kangwan N; Oh JY; Lee DY; Hahm KB
Expert Rev Gastroenterol Hepatol; 2017 Nov; 11(11):1059-1070. PubMed ID: 28707966
[TBL] [Abstract][Full Text] [Related]
18. Cancer Stem Cells in Prostate Cancer: Implications for Targeted Therapy.
Leão R; Domingos C; Figueiredo A; Hamilton R; Tabori U; Castelo-Branco P
Urol Int; 2017; 99(2):125-136. PubMed ID: 28142149
[TBL] [Abstract][Full Text] [Related]
19. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
Yan Y; Zuo X; Wei D
Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic antibodies against cancer stem cells: a promising approach.
Sneha S; Nagare RP; Priya SK; Sidhanth C; Pors K; Ganesan TS
Cancer Immunol Immunother; 2017 Nov; 66(11):1383-1398. PubMed ID: 28840297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]